Brief: Grifols Gets EMA Approval For Manufacture And Selling Of Egyptian Plasma
Dec 16 (Reuters) - Grifols SA GRLS.MC: RECEIVES EMA (EUROPEAN MEDICINES AGENCY) CERTIFICATION FOR EGYPTIAN PLASMA GEPD (GRIFOLS EGYPT FOR PLASMA DERIVATIVES) AUTHORIZED TO MARKET PLASMA PRODUCTS IN EUROPE Source text Further company coverage: GRLS.MC (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 567 69 66 00;))
Recent news on Grifols
See all newsSpanish stocks - Factors to watch on Nov 3
Brief: Grifols Approves Interim Dividend Of €0.15/Shr Payable On Dec 4
Brief: Grifols Q3 Group Profit €162 Mln
Refile: Grifols says Canada plasma license suspension has no impact on ongoing operations
Brief: Health Canada Suspends Licence Of Grifols Site In Winnipeg - Globe And Mail